Forest Investigative Site 3004 — National City, California

Forest Investigative Site 3004 is a clinical research site located in National City, California, United States 91950.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 3004 has participated in 1 clinical trials.

Therapeutic areas: Bipolar 1 Disorder.

Sponsors: Forest Laboratories.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in National City

Browse all research sites in California · View every site in National City

• Paradise Valley Hospital, 2400 E. 4th Street
• Synergy Clinical Research Center
• Research Site
• GSK Investigational Site
• Pfizer Investigational Site
• Synergy Clinical Research
• Local Institution
• Alkermes Investigational Site
• Synergy San Diego
• Novo Nordisk Investigational Site
• Synergy Research
• Novartis investigative site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 3004?

Forest Investigative Site 3004 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 3004 conducted?

Forest Investigative Site 3004 has 1 clinical trials on record. Their work covers Bipolar 1 Disorder.

Is Forest Investigative Site 3004 accredited by Crixeo Clinical Trials?

Forest Investigative Site 3004 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 3004?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.